Author
Listed:
- Zameer Shervani
(Food Energy Security Research Product Centre, Japan)
- Deepali Bhardwaj
(Centre for Skin and Hair Pvt. Ltd., India)
- Roma Nikhat
(Food Energy Security Research Product Centre, Japan)
- Aiman Ibbrahim
(Aligarh Muslim University, India)
- Intazam Khan
(Flushing Hospital Medical Center, USA)
- Umair Yaqub Qazi
(University of Hafr Al Batin, KSA)
- Ankira Agarwal
(Ram Manohar Lohia Hospital, India)
- Adil Ahmed Khan
(Hakeem Abdul Hameed Centenary Hospital, India)
- Sadia Hasan
(Jamia Millia Islamia, India)
- Abdullah Sherwani
(Aligarh Muslim University, India)
Abstract
The results of the fourth COVID-19 national serosurvey (June-July 2021) of India have been analysed. Much needed data of vaccine generated antibodies have been reported world first as recorded in Indian population on the ground in real. More than two-thirds of (67.6%) Indian population developed antibodies against the infection. This includes natural immunity build up due to infection and vaccine generated antibodies. Eleven states: Madhya Pradesh, Rajasthan, Bihar, Gujrat, Chhattisgarh, Uttarakhand, Uttar Pradesh, Andhra Pradesh, Karnataka, Tamil Nadu, and Odisha had sero positivity of >67.6%which was the national average. Ten other states registered
Suggested Citation
Zameer Shervani & Deepali Bhardwaj & Roma Nikhat & Aiman Ibbrahim & Intazam Khan & Umair Yaqub Qazi & Ankira Agarwal & Adil Ahmed Khan & Sadia Hasan & Abdullah Sherwani, 2022.
"4th National Sero Survey of India: Vaccine Generated Antibodies Enhancement,"
European Journal of Medical and Health Sciences, European Open Science, vol. 4(1), pages 27-32, January.
Handle:
RePEc:epw:ejmed0:v:4:y:2022:i:1:id:41132
DOI: 10.24018/ejmed.2022.4.1.1132
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:ejmed0:v:4:y:2022:i:1:id:41132. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support (email available below). General contact details of provider: https://eu-opensci.org/index.php/ejmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.